Immediate Impact
58 standout
Citing Papers
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Drug resistance in ovarian cancer: from mechanism to clinical trial
2024 Standout
Works of Colleen McCormick being referenced
Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
2023
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Colleen McCormick | 186 | 90 | 60 | 68 | 17 | 270 | |
| Oktay Erten | 192 | 39 | 81 | 62 | 21 | 301 | |
| Ebunoluwa Otegbeye | 82 | 111 | 37 | 71 | 19 | 305 | |
| Alexander V Sluijmer | 148 | 47 | 74 | 65 | 13 | 322 | |
| Serena Maria Boccia | 86 | 78 | 43 | 31 | 22 | 217 | |
| Caela Miller | 122 | 51 | 73 | 34 | 19 | 294 | |
| Koichi Udagawa | 59 | 36 | 44 | 59 | 15 | 251 | |
| Anna Germanová | 98 | 35 | 203 | 62 | 18 | 308 | |
| Heinrich Salzer | 204 | 57 | 91 | 13 | 14 | 311 | |
| Giorgia Dinoi | 124 | 54 | 198 | 36 | 21 | 275 | |
| Mehmet Anıl Onan | 87 | 16 | 68 | 70 | 21 | 233 |
All Works
Loading papers...